The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $125.70

Today's change+5.20 +4.32%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $125.70

Today's change+5.20 +4.32%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.

United Therapeutics Corp crosses above 20-day moving average

United Therapeutics Corp closed up sharply Friday, rallying (U.S.)$5.20 or 4.32% to (U.S.)$125.70 and crossing above its 20-day moving average. Over the last five days, shares have gained 3.90%, but are down 12.36% for the last year to date. Shares have outperformed the S&P 500 by 5.04% during the last year.

Key company metrics

  • Open(U.S.) $121.21
  • Previous close(U.S.) $120.50
  • High(U.S.) $126.15
  • Low(U.S.) $120.12
  • Bid / Ask(U.S.) $119.75 / (U.S.) $0.00
  • YTD % change-12.36%
  • Volume1,133,176
  • Average volume (10-day)769,364
  • Average volume (1-month)706,454
  • Average volume (3-month)646,515
  • 52-week range(U.S.) $97.52 to (U.S.) $169.89
  • Beta1.41
  • Trailing P/E8.84×
  • P/E 1 year forward8.33×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $14.22
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.51%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue409408413369
Total other revenue--------
Total revenue409408413369
Gross profit381385393368
Total cost of revenue2824201
Total operating expense2351701275
Selling / general / administrative140100725
Research & development6746350
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income174239285364
Interest income (expense), net non-operating-2-1-1-1
Gain (loss) on sale of assets00----
Other--------
Income before tax172239286364
Income after tax110162206236
Income tax, total617780128
Net income110162206236
Total adjustments to net income--------
Net income before extra. items110162206236
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items110162206236
Inc. avail. to common incl. extra. items110162206236
Diluted net income110162206236
Dilution adjustment--------
Diluted weighted average shares45464749
Diluted EPS excluding extraordinary itemsvalue per share2.433.504.394.84
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share2.433.504.394.84